Arrêté n° 25941/2014-MSANP du 22 septembre 2014
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Arrêté n° 25941/2014-MSANP du 22 septembre 2014 is the official MSANP identifier for “Réglementant la vente et l’utilisation des Tests de Diagnostic Rapide pour le traitement du paludisme à Madagascar”. Arrêté n° 25941/2014-MSANP du 22 septembre 2014 is the official identifier MSANP uses for this instrument.
- Instrument
- Arrêté
- Full name
- Arrêté n° 25941/2014-MSANP du 22 septembre 2014
- Category
- Registration
- Source publication
- French
- Readable HTML
- 1 language version
- Published
- —
- Effective
- 2014-09-22
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Réglementant la vente et l’utilisation des Tests de Diagnostic Rapide pour le traitement du paludisme à Madagascar
Complete two-page malaria RDT-specific order. It defines immunochromatographic tests detecting plasmodial antigens, requires National Malaria Programme technical specifications, identifies distribution settings and trained users, and states inArticle 6 that acquisition of these diagnostic tests does not require AMM. This exception is retained within this malaria-RDT instrument and is not generalized to all IVDs. Article 8 provides entry into force from signature, 22 September 2014; later amendments and currentness remain unverified. The preamble literally cites 14992/2012 with a 19 July 2013 date; this source inconsistency is retained.
Arrêté n° 25941/2014-MSANP du 22 septembre 2014 is the official identifier MSANP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.